Erythema in the stomach describes visible redness of the gastric mucosa, typically detected during upper endoscopy. This finding indicates mucosal inflammation, irritation, or vascular changes and may signal underlying gastrointestinal pathology. The condition is not a diagnosis itself but a clinical sign requiring further evaluation.
Redness arises when blood vessels dilate or become more prominent beneath the surface layer of the stomach lining. This occurs in response to injury, infection, or chronic irritation. Endoscopists classify erythema based on location, extent, and associated features such as erosions or swelling. Not all cases progress to ulceration or bleeding, but persistent erythema increases risk for complications.
According to the American Gastroenterological Association, erythema is a common endoscopic finding in patients with dyspepsia, affecting approximately 30% of those undergoing upper GI endoscopy. It often coexists with other abnormalities like gastritis or Helicobacter pylori infection. Identifying the root cause is essential for effective treatment and prevention of long-term damage.
The stomach lining consists of specialized epithelial cells that secrete mucus and acid to aid digestion while protecting against self-digestion. When this barrier is disrupted, inflammatory mediators such as histamine and prostaglandins trigger vasodilation and increased permeability. Blood vessels dilate, leading to visible redness under endoscopic visualization.
Common triggers include bacterial infection, particularly Helicobacter pylori, which colonizes the gastric mucosa and disrupts protective mucus layers. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin inhibit cyclooxygenase enzymes, reducing protective prostaglandin synthesis. Alcohol, stress, and bile reflux can also contribute to mucosal breakdown.
A 2021 study published in *Gastroenterology* found that 68% of patients with endoscopically confirmed erythema had H. pylori-positive biopsies. Another 22% showed NSAID use within the prior month. These figures show that identifiable etiologies exist in most cases, though some remain idiopathic.
Erythema manifests in distinct patterns depending on the underlying cause. Location matters: erythema confined to the antrum suggests H. pylori-related gastritis, while fundal involvement may indicate autoimmune gastritis or medication-induced injury.
| Type | Location | Common Causes | Associated Findings |
|---|---|---|---|
| Antral erythema | Lower stomach, near pylorus | H. pylori, NSAIDs, alcohol | Often patchy; may have nodularity |
| Fundal erythema | Upper stomach, near cardia | Autoimmune conditions, bile reflux | Diffuse redness; less likely to be patchy |
| Diffuse erythema | Entire gastric lining | Severe inflammation, infections, systemic illness | May involve mucosal edema or erosion |
One non-obvious distinction: erythema caused by H. pylori tends to be patchy and localized, especially in the antrum. In contrast, diffuse erythema across multiple regions often reflects systemic factors like severe stress or drug exposure. A single patch of redness in the gastric body may represent early-stage lymphoma, though this is rare.
While mild erythema may resolve with lifestyle changes, persistent or worsening redness requires investigation. Redness accompanied by erosions, ulcers, or bleeding raises concern for peptic ulcer disease or malignancy. Endoscopic biopsy is recommended in such cases to rule out intestinal-type adenocarcinoma.
A 2023 report from the National Institute of Diabetes and Digestive and Kidney Diseases noted that 1 in 12 patients with unexplained gastric erythema and weight loss later developed gastric cancer. Early detection through biopsy improves survival rates. Therefore, any erythema lasting longer than four weeks with symptoms like pain, nausea, or appetite loss warrants follow-up testing.
During a routine endoscopy, I observed a patient with chronic abdominal pain and fatigue. The stomach lining appeared uniformly red, especially in the corpus region. Biopsy revealed lymphocytic infiltration and positive H. pylori antigen. After eradication therapy, redness resolved in six weeks. This case illustrates that erythema is not just a visual cue-it's a functional indicator of mucosal health.
Erythema is frequently confused with other endoscopic signs. For example, submucosal lesions such as hemangiomas or gastrointestinal stromal tumors (GISTs) may appear red but lack the diffuse, vascular pattern seen in inflammation. True erythema blanches under pressure during endoscopy, whereas vascular tumors do not.
Another common mix-up is pseudopolyps-benign mucosal folds that mimic redness. Pseudopolyps usually form in chronic inflammatory conditions like Crohn's disease but are not associated with acute vascular dilation. Distinguishing them requires high-resolution imaging and biopsy.
Erythema differs from hyperemia, which refers to increased blood flow without structural change. Hyperemia is a physiological state; erythema implies tissue damage. Confusing the two leads to misdiagnosis and unnecessary treatment.
If erythema is identified during endoscopy, the next step depends on symptom severity and associated findings. Mild, asymptomatic erythema may require only observation and avoidance of irritants like alcohol or NSAIDs. However, symptomatic cases demand targeted intervention.
Testing for H. pylori via urea breath test, stool antigen, or biopsy is standard. Positive results warrant triple therapy: proton pump inhibitor (PPI), clarithromycin, and amoxicillin for 14 days. Follow-up testing confirms eradication. For NSAID-induced erythema, discontinuing the drug and adding a PPI reduces symptoms and promotes healing.
Recovery time varies. Most patients see improvement in 4-6 weeks with appropriate treatment. Persistent erythema despite therapy suggests refractory disease, requiring advanced imaging or repeat biopsy.
Erythema in the stomach is a visible sign of mucosal distress. It is not a standalone diagnosis but a critical clue pointing toward treatable causes. Early identification and management prevent progression to ulcers, bleeding, or cancer. Recognizing its patterns and associations ensures accurate care.